GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: ACT-078 | Eloxatin®
                                 oxaliplatin is an approved drug (FDA (2002)) Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Oxaliplatin is a platinum-based chemotherapy drug in the same class as carboplatin and cisplatin. Its main action is as a nucleic acid alkylating agent (see Clinical Data tab for further details). It is a platinum-chelating molecular complex (see CID 9887053).
                                    
                                 | 
| Classification  | |
| Compound class | Synthetic organic | 
| Approved drug? | Yes. US FDA (2002) | 
| WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 6012 | oxaliplatin | 
| Synonyms  | 
| ACT-078 | Eloxatin® | 
| Database Links  | |
| CAS Registry No. | 63121-00-6 | 
| ChEMBL Ligand | CHEMBL414804 | 
| DrugBank Ligand | DB00526 | 
| GtoPdb PubChem SID | 178104005 | 
| Search PubMed clinical trials | oxaliplatin | 
| Search PubMed titles | oxaliplatin | 
| Search PubMed titles/abstracts | oxaliplatin | 
| Wikipedia | Oxaliplatin |